Zhu et al. reported that EIF5A2 was upregulated in colorectal carcinoma tissues and the overexpression of EIF5A2 enhanced CRC cell motility and invasion by enhancing the enrichment of c-myc on the promoter of MTA126. Here, EIF5A2 is linked to colorectal carcinoma.